News
Biosenta Inc. Achieves Major Breakthroughs in Bench Scale Production and Innovative Input Viability
Breakout Antimicrobial Biotechnology Quietly Building Success
The Watchlist: Biosenta Inc. announces licensing agreement
Biosenta Inc. Announces Licensing Agreement with Lightweight Concrete Solutions
Biosenta Announces Engagement of Oak Hill Financial Inc.
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Fillerâ„¢
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Fillerâ„¢
Biosenta Inc. announces further advances in research and development of Tri-Fillerâ„¢
Solution fighting a drug-resistant fungus in hospitals of U.S. and Canada
Biosenta announces further advances in research and development of Tri-Fillerâ„¢
Biosenta announces termination of joint venture and issuance of securities
Biosenta announces entering into of agreement to terminate joint venture
Biosenta Inc. ceases negotiations with Voran Group Ventures Ltd.
Summit-bound CEO sees promising future for Edmonton region
University of Calgary researchers encouraged by early findings in the fight against germs
University of Calgary very encouraging anti-bacterial Biosenta particles for construction industry
01/26/2021 - Biosenta Announces Record Revenues
12/22/2020 - U.S. Partner Secures Licensing Rights
09/24/2020 - Biosenta and University of Calgary enter into a four year partnership